BioInvent International AB is a clinical-stage biotech company focused on immuno-oncology antibody drug development, with an integrated contract manufacturing business unit (BioInvent Manufacturing) that has offered CDMO/CMO services since 1988. The cGMP manufacturing facility in Lund, Sweden produces monoclonal antibodies and fusion proteins using fully disposable technology in 40L to 1,000L bioreactors. Licensed by the Swedish Medical Products Agency and has French CIR accreditation. Has produced clinical-grade drug substance for trials in Europe, USA, Japan, Australia, and China.
monoclonal antibody cGMP manufacturing, disposable bioreactor technology, cell line development (royalty-free GS knocked CHO K1), antibody process development and optimization, IMPD/IND preparation
1 site worldwide
Involvement in 1 clinical trial
No reviews available yet.
No documents available.